African News

Colon Cancer Update: A Primer for Sierra Leone

27 February 2014 at 09:29 | 1521 views

Essay

By Dr. Angela M. Dumbuya, DNP/Nurse Practitioner,

The Medical Center, Columbus, Georgia, USA.

Introduction

In the past several years, relatives, friends, and acquaintances have been diagnosed with cancer, and, sadly enough, some of them have succumbed to the disease. As an advanced certified oncology nurse practitioner with many years of experience, I would like to take this opportunity to present to the Sierra Leonean and African diaspora community in general essays on four of the most prevalent types of cancer; these are colorectal, breast, lung, and prostate cancer.

Cancer, a non-communicable disease, has been on the rise in Africa so much so that it has been documented by the American Cancer Society (ACS) and the World Health Organization (WHO) as a very serious public health problem.

The increase in cancer rates is the result of Africans’ changing diet and lifestyles, coupled with a multitude of environmental factors on the continent. One of these is aflatoxin which is a toxin found in maize, sorghum, and groundnuts among others. Aflatoxins are among the most carcinogenic substances found in the environment. Aflatoxin is a source of hepatocarcinoma or primary liver cancer which is very high in sub-Saharan Africa. The International Agency for Research and Cancer (IARC) estimated that 715,000 new cases of cancer were diagnosed in 2008, and about 542,000 of those so diagnosed died of the disease in the same year. These numbers are expected to increase to 1.28 million new cases and about 970,000 deaths by 2030.

What is Cancer?

Cancer is a group of diseases that have the following characteristics. Each group of disease is made up of cancer cells that are capable of proliferating and dividing uncontrollably.

Collectively they have the ability to invade other tissues and spread (or metastasize) to other areas of the human body. According to studies published by many researchers (including Merkle & Loescher 2005; Volker 2005), cancer cells lack apoptosis, meaning that they do not die like normal cells do. All cancers begin in the cell unit. The cell is the human body’s basic unit of life. The body is inhabited by many different types of cells. For instance, the lungs have their own cells, the colon has its own cells, and the prostate has its own cells. The breast, brain, liver, pancreas, and spleen all have their own cells. Normal and healthy cells have a normal pattern of behaving. These cells are produced in the bone marrow by the parent cell which is called the stem cell. These cells can differentiate into red blood cells (RBC), white blood cell (WBC), and platelets (PLT).

After completion of the differentiation process, the cells become mature and some leave the bone marrow and migrate into the blood stream. If they do not become mature cells they are referred to as blast cells which is an indication of the presence of Leukemia or blood cancer. In a normal cell, the cell structure has the ability to grow old or be damaged and when that happens that cell dies and is replaced by another. The life span of a cell depends on the type of cell; for example the RBC has a life span of 120 days, but for people with sickle cell the life span is between 15-20 days. This is one of the reasons why sickle cell patients require frequent red blood cell transfusions. In cancer cells this normal pattern of cell growth, differentiation, and maturation does not take place. And as we get older or come in contact with certain carcinogens, the DNA of a normal cell is susceptible to damage or change in its structure. Any changed or damaged cell becomes a mutated cell. As a result of this mutation, the cell becomes abnormal.

This has huge implications for the functions of the cell. A mutated cell, under the right environment, loses its ability to die a normal death and can spread to other organs in the body.

Therefore, cancer begins to grow when an organ produces a lot of abnormal cells in combination with other abnormal or mutated cells that refuse to die; these cells then form a mass of tissue called a tumor. However, not all tumors are cancerous. Some are benign and some are malignant. Malignant tumors are cancerous.

Colorectal Cancer and its Risk Factors

According to figures released by the ACS in 2013, colorectal cancer (or cancer of the colon and rectum which are parts of the gastrointestinal track, GI) is both the third most occurring cancer among men and women and the third leading cause of cancer-related deaths for men and women in the United States.

The colon, also called the large bowel, is about five feet long. Most mineral and water contents are absorbed from the large bowel. The colon is divided into four sections: ascending colon or right-sided colon, the transverse colon which crosses the body from right to left, the descending colon or left-sided colon, and the sigmoid colon which, with its “S” shape, joins the rectum. Most colon cancers develop in the sigmoid colon.

Colorectal cancer develops over a long period of time. Usually it takes about ten years from cell mutation to tumor development. The life time risk of developing colorectal is 1:20 (this means that one in every twenty persons alive today above the age of 50 years will develop colorectal cancer in their life time). About 72 percent of cases arise in the colon and about 28 percent in the rectum. In 2012, 152,463 new cases of colorectal cancers were diagnosed in thUnited States with 51,690 recorded deaths from the disease. Worldwide 60 percent of all cases of this type of cancer occur in the developed regions of the world. The lowest rates are in Africa with the exception of South Africa. In most West African countries like Sierra Leone, the rates of colorectal cancer among the indigenous populations are even lower. Research published by Dr. D.O. Irabor in 2008 suggested that this low incidence of colorectal cancer among West Africans
may be related to either anthropomorphic or environmental factors such as abundant sunlight.

Among the most prevalent risk factors in the development of colorectal cancer is
age. Various studies have shown that more than 90 percent of people who die from this disease are aged 50 years or older. Another risk factor is a history of polyps in the rectum and colon especially for people that have the hereditary non-polyposis colon cancer or familial adenomatous polyposis colon cancer. A family (mother, father, brothers, sisters, and children) history of colon cancer is also a risk factor, as is one’s racial background. In the United States, African Americans have a higher incidence (20 percent) of colorectal cancer and a higher
mortality (45 percent) rate than their Caucasian counterparts. In addition, a high fat diet, especially one involving animal fat (red meat), low calcium or folate diet, and low fiber diets, can increase the risk of someone developing colon cancer. A high fat diet, coupled with a lack of daily exercise often leads to severe obesity. Many empirical studies have established a causal link between obesity and colorectal cancer. A medical condition such as Type II Diabetes Mellitus can lead to colorectal cancer. Other risk factors include cigarette smoking, inflammatory bowel disease, and alcohol usage. The overall incidence and mortality of colorectal cancer is between 35-40 percent higher in men than in women. The reasons for this are not yet completely understood.

What are the signs and symptoms of Colorectal Cancer?

Among the signs and symptoms of colorectal cancer are: a change in one’s bowel habits such as constipation or diarrhea, rectal bleeding, bright red or dark red stool, narrow or pencil like stool, abdominal pain especially in the lower abdomen, fatigue, unexplained weight loss, and nausea or vomiting. An individual’s chance of surviving colorectal cancer is very high if the cancer is detected very early and the polyps removed. Therefore, it is highly recommended that individuals check with their family care providers or their nurse practitioners about screening for this type of cancer. The ACS recommends screening with a colonoscopy for the general population to begin at age 50. However, screening for people with the above-referenced risk factors should begin much earlier than the recommended age.

Among the recommended and proven screening methods are:

1. Fecal Occult blood test (FOBT): This tests for blood in the stool and is done

every 1-2 years in people ages 50-80.

2. Sigmoidoscopy: A lighted instrument call a sigmoidoscpe is inserted into the

rectum and lower colon to check for growth, cancer, and pre-cancer cells every 3-5 years.

3. Colonoscopy: This examines the rectum and the entire colon using a

colonoscope. A thorough cleaning of the colon is necessary before this test is done. This

test checks for abnormal growth, polyps, and cancer cells. If any abnormality is found

it is biopsied (a specimen is taken from the abnormal tissue and sent for pathologic

analysis). If the test does not show any abnormality, it is repeated every ten years.

4. Double contrast barium enema: This is an x-ray of the entire colon and rectum.

5. Digital rectal exam: This is done during the yearly physical exam to check for

abnormality and blood in the lower portion of the rectum.

Often cost, lack of medical insurance, and lack of access to health care facilities and providers can be barriers to colorectal cancer screening. Sometimes inadequate communication by health care providers and end users’ low levels of education can also delay cancer screening.

Therefore, in order to ameliorate the situation, every effort has to be made to remove personal (usually fear of the unknown or refusal to consult with one’s primary care provider) and structural barriers to cancer screening. One way to remove structural barriers is to deploy community-based organizations to promote screening by sending reminders to patients and encourage the use of navigators. These are nurses, social workers, and lay people who work on behalf of patients and their families to help facilitate timely access to quality medical care.

Conclusion

It is a well-known medical fact, backed up by many studies, that early detection of cancer can save lives. The ACS has recommended colorectal screening for the general population to begin by age 50. For people who have a higher burden of developing colorectal cancer either because of family history or other medical predispositions, it is recommended that screening should begin earlier than the recommended age. They are encouraged to start a dialogue with their family health care providers and review the necessary screening guidelines for high risk patients.

The American Gastroenterological Association (AGA) and the ACS have all recommended colonoscopy as the most effective screening method for people who have an increased risk of developing colorectal cancer.

Editor’s Note: For more information on this article, especially references, readers can contact Dr. Angela Memuna Dumbuya at: angeladumbuya@gmail.com.

Comments